Lesion localization before SBRT (fiducial placement)
Percutaneous placement of small metallic markers (fiducials) in or near a tumor to enable precise stereotactic radiotherapy targeting.
The information below is provided for general educational purposes only. It describes the procedure in general terms and may not apply to your specific situation. Only your interventional radiologist can provide you with personalized information adapted to your case.
What does this intervention involve?
Background and indications
Stereotactic body radiation therapy (SBRT) requires extremely precise targeting. Metallic markers (fiducials) are placed in the tumor to serve as visible references on planning and treatment images, particularly for lung or liver tumors that move with breathing.
Benefits
Improved radiotherapy accuracy, reduced safety margins needed and better healthy tissue preservation.
Procedure
Under local anesthesia, 1-3 small metallic markers (gold or titanium) are implanted in or around the tumor under CT guidance. The procedure lasts 15-30 minutes.
Risks
Pneumothorax (for lung tumors), minor bleeding, marker migration. Overall risk is low.
Recovery and follow-up
Same-day discharge. Radiotherapy is planned a few days to 2 weeks after fiducial placement.
Practical information
Local anesthesia. Outpatient procedure (return home the same day).
This information does not replace a medical consultation. Each procedure is adapted to the patient's individual situation. Your doctor will explain the specific details, expected benefits and potential risks during your consultation.
Doctors and centers/departments performing this intervention
3 doctors
Dr Vincent DUROUS
Radiologue interventionnelAnnecy, Argonay
Dr Quentin LAFERTé
Radiologue interventionnelSaint-Quentin
Dr Nicolas VILLARD
Radiologue interventionnelLausanne